Omnicell (OMCL) Construction in Progress (2014 - 2018)
Omnicell's (OMCL) quarterly Construction in Progress came in at $10.7 million in Q4 2018, up 9.1% year-over-year from $9.8 million in Q4 2017, and down 6.32% quarter-over-quarter from $11.4 million in Q3 2018.
Analysis
Omnicell (OMCL) Construction in Progress (2014 - 2018) Analysis & Trends
Omnicell (OMCL) has reported Construction in Progress for 5 consecutive years, with $10.7 million the latest figure, recorded in Q4 2018.
- On a quarterly basis, Construction in Progress rose 9.1% year-over-year to $10.7 million in Q4 2018; TTM through Dec 2018 was $10.7 million, a 9.1% increase from a year earlier, with the FY2018 full-year figure at $10.7 million, up 9.1% from the prior year.
- Construction in Progress was $10.7 million for Q4 2018 at Omnicell, down from $11.4 million in the prior quarter.
- Over five years, Construction in Progress peaked at $12.5 million in Q2 2018 and troughed at $1.5 million in Q4 2014.
- A 5-year average of $7.6 million and a median of $7.5 million in 2016 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress surged 137.39% in 2015 and increased 8.22% in 2017, its largest moves.
- Over 5 years, Construction in Progress stood at $1.5 million in 2014, then jumped by 137.39% to $3.7 million in 2015, then jumped by 97.51% to $7.2 million in 2016, then jumped by 36.08% to $9.8 million in 2017, then advanced by 9.1% to $10.7 million in 2018.
- The last three Construction in Progress figures came in at $10.7 million (Q4 2018), $11.4 million (Q3 2018), and $12.5 million (Q2 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 911.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | - |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 10.71 Mn |
| Sep 30, 2018 | 11.43 Mn |
| Jun 30, 2018 | 12.49 Mn |
| Mar 31, 2018 | 11.33 Mn |
| Dec 31, 2017 | 9.81 Mn |
| Sep 30, 2017 | 8.08 Mn |
| Jun 30, 2017 | 9.29 Mn |
| Mar 31, 2017 | 7.63 Mn |
| Dec 31, 2016 | 7.21 Mn |
| Sep 30, 2016 | 7.47 Mn |
| Jun 30, 2016 | 5.93 Mn |
| Mar 31, 2016 | 5.41 Mn |
| Dec 31, 2015 | 3.65 Mn |
| Sep 30, 2015 | 4.90 Mn |
| Jun 30, 2015 | 3.98 Mn |
| Dec 31, 2014 | 1.54 Mn |